ADVERTISEMENT

Conference Report

ERS 2022 — Bronchodilators don’t improve symptoms in smokers without airflow obstruction

Drishti Agarwal   |   09 September 2022

Takeaway

  • Inhaled bronchodilators do not improve respiratory symptoms in symptomatic, tobacco-exposed individuals with preserved spirometry, only those with lung damage enough to disrupt normal spirometry readings benefit from bronchodilator therapy.

A long-acting bronchodilator is the first choice for therapy in patients with chronic obstructive pulmonary disease (COPD). Spirometry shows evidence...

          

November Challenge

Ends in 1d 7h
left
right

Topic Challenges

left
right